Produto adicionado correctamente ao carrinho.

discount label
H-SIINF^EKL-OH
Ver 3D

Biosynth logo

H-SIINF^EKL-OH

Ref. 3D-PP48994

Tamanho indefinidoA consultar
Entrega estimada em Estados Unidos, Sexta-feira 13 de Dezembro de 2024

Informação sobre produto

Nome:
H-SIINF^EKL-OH
Descrição:

Peptide H-SIINF^EKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SIINF^EKL-OH include the following: A supramolecular vaccine platform based on alpha-helical peptide nanofibers Y Wu , PK Norberg, EA Reap , KL Congdon - ACS biomaterials , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsbiomaterials.7b00561 Peptide-based cancer vaccine delivery via the STINGΔTM-cGAMP complex Y He , C Hong , SJ Fletcher, AG Berger - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202200905 Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters X Lu, JS Gibbs, HD Hickman , A David - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1208696109 Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific T Fifis, P Mottram, V Bogdanoska, J Hanley - Vaccine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0400427X Development of a Stable Peptide-Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry SC Uslu , UJ Lee , S Tavakolpour - ACS Pharmacology & , 2024 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsptsci.3c00268 Well-Defined Mannosylated Polymer for Peptide Vaccine Delivery with Enhanced Antitumor Immunity S Lv , K Song , A Yen , DJ Peeler - Advanced , 2022 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adhm.202101651 Cutting edge: N-hydroxy peptides: a new class of TCR antagonists S Hin, C Zabel, A Bianco , G Jung - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/5/2363/32894 Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and PJ Chefalo, CV Harding - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/3/1274/35053 26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide P Cascio, C Hilton , AF Kisselev, KL Rock - The EMBO , 2001 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/20.10.2357 Exact prediction of a natural T cell epitope O Rötzschke , K Falk, S Stevanovic - European journal of , 1991 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830211136 Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes NAW Lemmermann , K Gergely, V Böhm - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02087-09 Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells NA Kukutsch, S Rossner, JM Austyn, G Schuler - Journal of investigative , 2000 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022202X15409935 Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel M Kamalov , H Kahlig, C Rentenberger, ARM Mullner - Scientific Reports, 2019 - nature.comhttps://www.nature.com/articles/s41598-019-39148-8 Tapasin enhances MHC class I peptide presentation according to peptide half-life M Howarth , A Williams, AB Tolstrup - Proceedings of the , 2004 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0306294101 Proteasomes and antigen presentation: evidence that a KEKE motif does not promote presentation of the class I epitope SIINFEKL M Gonciarz-Swiatek, M Rechsteiner - Molecular immunology, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589005004104 Sortase-mediated modification of alphaDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes LK Swee, CP Guimaraes, S Sehrawat - Proceedings of the , 2013 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1214994110 Investigation of antigen delivery route in vivo and immune-boosting effects mediated by pH-sensitive liposomes encapsulated with Kb-restricted CTL epitope KY Lee, E Chun , BL Seong - Biochemical and biophysical research , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X02967112 In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles KS Kawamura, RC Su , LT Nguyen - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/168/11/5709/34240 Both human and mouse cells expressing H-2Kb and ovalbumin process the same peptide, SIINFEKL K Falk, O Rötzschke , S Faath, S Goth, I Graef - Cellular , 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712128 MHC/peptide binding studies indicate hierarchy of anchor residues K Deres, W Beck, S Faath, G Jung, HG Rammensee - Cellular immunology, 1993 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0008874983712281 Brucella peptide cross-reactive major histocompatibility complex class I presentation activates SIINFEKL-specific T cell receptor-expressing T cells JS Harms, M Khan, C Hall , GA Splitter - Infection and , 2018 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/iai.00281-18 Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase J Beninga, KL Rock, AL Goldberg - Journal of Biological Chemistry, 1998 - ASBMBhttps://www.jbc.org/article/S0021-9258(18)80196-X/abstract In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability GB Lipford , S Bauer, H Wagner , K Heeg - Vaccine, 1995 - Elsevierhttps://www.sciencedirect.com/science/article/pii/0264410X95933209 A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway GA Pietersz, W Li, V Apostolopoulos - Vaccine, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X0000373X Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules E Schott, N Bertho , Q Ge - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.212515399 Comparison of protein and peptide targeting for the development of a CD169-based vaccination strategy against melanoma D Van Dinther , H Veninga, M Revet - Frontiers in , 2018 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2018.01997/full A SIINFEKL-based system to measure MHC class I antigen presentation efficiency and kinetics D Dersh , JW Yewdell , J Wei - Antigen Processing: Methods and Protocols, 2019 - Springerhttps://link.springer.com/protocol/10.1007/978-1-4939-9450-2_9 Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2) CL Nguyen, ML Salem , MP Rubinstein, M Demcheva - Vaccine, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X03000963 Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum CJ Hilton , AM Dahl, KL Rock - The Journal of Immunology, 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/166/6/3952/70418 Anti-Peptide Antibody Blocks Peptide CJ Hilton , AM Dahl, KL Rock - scholar.archive.orghttps://scholar.archive.org/work/c72ogauyunfuhgex7k36gpd7w4/access/wayback/http://www.umassmed.edu/uploadedFiles/otm2/Ready_to_sign/00-32%20Ref.pdf A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma C Capasso, A Magarkar , V Cervera-Carrascon - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1319028 T cell determinants incorporating beta-amino acid residues are protease resistant and remain immunogenic in vivo AI Webb , MA Dunstone , NA Williamson - The Journal of , 2005 - journals.aai.orghttps://journals.aai.org/jimmunol/article/175/6/3810/73297 Functional screening of a retroviral peptide library for MHC class I presentation AB Tolstrup, M Duch, I Dalum, FS Pedersen - Gene, 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378111900005722 Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody A Porgador , JW Yewdell , Y Deng, JR Bennink - Immunity, 1997 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(00)80447-1.pdf Peptide-loaded dendritic cells prime and activate MHC-class I-restricted T cells more efficiently than protein-loaded cross-presenting DC aca– Met, S Buus , MH Claesson - Cellular immunology, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S000887490300128X pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects A Faham, T Herringson, C Parish, A Suhrbier - Vaccine, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0264410X11010772 Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide A Craiu, T Akopian, A Goldberg - Proceedings of the , 1997 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.94.20.10850 Analysis of the proteolytic steps involved in MHC class I presentation of the ovalbumin epitope SIINFEKL A Craiu - 1997 - search.proquest.comhttps://search.proquest.com/openview/dc58025ab6af04f400622af0d7a743d2/1?pq-origsite=gscholar&cbl=18750&diss=y Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis A Carambia, C Gottwick, D Schwinge, S Stein - , 2021 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/imm.13298

Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:

Propriedades químicas

MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:

Informação sobre riscos

Número ONU:
EQ:
Classe:
Frases H:
Frases P:
Proibido de voar:
Informação sobre riscos:
Grupo de Embalagem:
LQ:

Consulta técnica sobre: 3D-PP48994 H-SIINF^EKL-OH

Por favor, utilize o carrinho para solicitar um orçamento ou uma encomenda

Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.

* Campos obrigatórios
Bem-vindo à CymitQuimica!Usamos cookies para melhorar sua visita. Não incluímos publicidade.

Consulte a nossa Política de Cookies para mais detalhes ou ajuste suas preferências em "Configurar".